Literature DB >> 2293506

The major histocompatibility complex: the value of extended haplotypes in the analysis of associated immune diseases and disorders.

M S Kruskall1.   

Abstract

Major histocompatibility complex antigens are critical to an animal's immune response. In most animals, the extreme polymorphism of MHC molecules complicates studies of the role of this complex in the immune response. In mice, however, MHC haplotype-homozygous inbred strains have been developed which are invaluable in the study of the immune system and the search for immune response genes. The human MHC bears many similarities to its murine equivalent with regard to antigen structure and polymorphism; furthermore, a number of combinations of specific MHC alleles between HLA-B and HLA-DR/DQ (extended haplotypes) are found in people more commonly than predicted by individual allele frequencies. Over 30 percent of Caucasian haplotypes are extended haplotypes, and over 55 percent of individuals have at least one extended haplotype. Examples of the same extended haplotype, even in unrelated individuals, should either all have or lack any gene within the MHC region. The value of considering extended haplotypes in searching for associations between the MHC and diseases, or immune response, is shown in three examples: congenital adrenal hyperplasia, hepatitis B immunization, and transfusion-associated graft-versus-host disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293506      PMCID: PMC2589374     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  35 in total

1.  Genetic prediction of nonresponse to hepatitis B vaccine.

Authors:  C A Alper; M S Kruskall; D Marcus-Bagley; D E Craven; A J Katz; S J Brink; J L Dienstag; Z Awdeh; E J Yunis
Journal:  N Engl J Med       Date:  1989-09-14       Impact factor: 91.245

Review 2.  T-lymphocyte-antigen interactions in transplant rejection.

Authors:  A M Krensky; A Weiss; G Crabtree; M M Davis; P Parham
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

3.  The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.

Authors:  M Thaler; A Shamiss; S Orgad; M Huszar; N Nussinovitch; S Meisel; E Gazit; J Lavee; A Smolinsky
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

4.  Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan.

Authors:  T Juji; K Takahashi; Y Shibata; H Ide; T Sakakibara; T Ino; S Mori
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

5.  Possible genetic linkage disequilibrium between HLA and the 21-hydroxylase deficiency gene (congenital adrenal hyperplasia).

Authors:  M S Pollack; L Levine; M Zachmann; A Prader; M New; S Oberfield; B Dupont
Journal:  Transplant Proc       Date:  1979-06       Impact factor: 1.066

Review 6.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

7.  Graft-versus-host reactions induced by transplantation of parental strain thymus in neonatally thymectomized F1 hybrid mice.

Authors:  O Stutman; E J Yunis; P O Teague; R A Good
Journal:  Transplantation       Date:  1968-07       Impact factor: 4.939

8.  Genetic control of the antibody response: relationship between immune response and histocompatibility (H-2) type.

Authors:  H O McDevitt; A Chinitz
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

9.  Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn.

Authors:  R Parkman; D Mosier; I Umansky; W Cochran; C B Carpenter; F S Rosen
Journal:  N Engl J Med       Date:  1974-02-14       Impact factor: 91.245

10.  Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusion.

Authors:  P L Weiden; N Zuckerman; J A Hansen; G E Sale; K Remlinger; T M Beck; C D Buckner
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

View more
  6 in total

Review 1.  Extreme genetic risk for type 1A diabetes in the post-genome era.

Authors:  Erin E Baschal; George S Eisenbarth
Journal:  J Autoimmun       Date:  2008-05-01       Impact factor: 7.094

2.  Transfer of multiple loci of donor's genes to induce recipient tolerance in organ transplantation.

Authors:  Tong Li; Wenqian Zhang; Qing Xu; Shentao Li; Xuehong Tong; Jie Ding; Hui Li; Shengcai Hou; Zhidong Xu; David M Jablons; Liang You
Journal:  Exp Ther Med       Date:  2018-04-13       Impact factor: 2.447

Review 3.  Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects.

Authors:  Mahendra Kumar Verma; Kota Sobha
Journal:  Inflamm Res       Date:  2015-07-07       Impact factor: 4.575

Review 4.  Application of pharmacogenomics to vaccines.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Pharmacogenomics       Date:  2009-05       Impact factor: 2.533

Review 5.  Vaccine immunogenetics: bedside to bench to population.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-07-01       Impact factor: 3.641

Review 6.  Vaccinomics and Adversomics in the Era of Precision Medicine: A Review Based on HBV, MMR, HPV, and COVID-19 Vaccines.

Authors:  Jasna Omersel; Nataša Karas Kuželički
Journal:  J Clin Med       Date:  2020-11-05       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.